Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
22,19 USD | +3,45% | -4,19% | -4,97% |
Attività
Numero di dipendenti: 59
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Timothy Rolph
FOU | Founder | 70 | 01/04/17 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
William White
DFI | Director of Finance/CFO | 51 | 01/04/19 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 01/05/22 |
Patrick Lamy
PRN | Corporate Officer/Principal | 51 | 01/01/23 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 01/10/18 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 01/01/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 01/01/17 |
Jane Henderson
BRD | Director/Board Member | 58 | 23/04/19 |
Mark Iwicki
CHM | Chairman | 57 | 01/11/18 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 01/09/18 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 09/06/20 |
Jonathan Young
FOU | Founder | 54 | 01/04/17 |
Judy Chou
BRD | Director/Board Member | 58 | 12/07/21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 01/06/18 |
Yuan Xu
BRD | Director/Board Member | 56 | 22/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 69 151 007 | 58 792 395 ( 85,02 %) | 0 | 85,02 % |
Coordinate società
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-4,97% | 1,48 Mrd | |
+18,43% | 122 Mrd | |
+19,81% | 112 Mrd | |
-23,74% | 19,33 Mrd | |
-18,45% | 16,17 Mrd | |
-19,97% | 15,6 Mrd | |
-49,33% | 14,65 Mrd | |
+57,08% | 14,34 Mrd | |
+7,95% | 14 Mrd | |
+126,04% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione AKRO
- Società Akero Therapeutics, Inc.